A pilot study of vidofludimus calcium for treatment of primary sclerosing cholangitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A pilot study of vidofludimus calcium for treatment of primary sclerosing cholangitis

Published:2022-03-03 Issue:7 Volume:6 Page:1589-1597
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Carey Elizabeth J.,Eaton John,Clayton Mitchell,Gossard Andrea,Iqbal Sara,Ullah Hamid,Zhang Nan,Butterfield Richard,Lindor Keith D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1926

Reference15 articles.

1. Primary sclerosing cholangitis;Lancet,2013

2. Primary sclerosing cholangitis: epidemiology, genetics, diagnosis, and current management;Clin Liver Dis (Hoboken),2020

3. ACG clinical guideline: Primary Sclerosing Cholangitis;Am J Gastroenterol,2015

4. Primary sclerosing cholangitis: a clinical update;Br Med Bull,2015

5. Surrogate endpoints for clinical trials in primary sclerosing cholangitis: review and results from an international PSC study group consensus process;Hepatology,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis;BMC Medical Genomics;2024-06-11

2. Navigating the liver landscape: upcoming pharmacotherapies for primary sclerosing cholangitis;Expert Opinion on Pharmacotherapy;2024-05-02

3. Novel preclinical developments of the primary sclerosing cholangitis treatment landscape;Expert Opinion on Investigational Drugs;2024-03-18

4. Recent Advances in the Management of Primary Sclerosing Cholangitis;Clinical Gastroenterology and Hepatology;2023-07

5. High throughput drug screening identifies resveratrol as suppressor of hepatic SELENOP expression;Redox Biology;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3